Harissios Vliagoftis

University of Alberta

H指数:39

被引数:4,144

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IgE allergy testing utilization: next steps from a provincial quality improvement initiative

IgE过敏测试利用：省级质量改进倡议的下一步措施

Clinical Biochemistry

IF2.1

2026-09-170

PRE

Mucosal adjuvant activity of a PAR-2–activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime–boost influenza vaccination model

PAR-2激活肽的黏膜佐剂活性增强淋巴结免疫细胞招募，并在初始-加强流感疫苗接种模型中促进免疫细胞活化

Vaccine

IF3.5

2026-09-040

OAAI

Asthma: Is It Time for Monocytes to Share the Spotlight?

哮喘：是时候让单核细胞分享聚光灯了吗？

Cells

IF5.2

2026-07-280

Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge

轻度哮喘患者气道中过敏原激发试验前后单核细胞趋化因子

Allergy

IF12

2025-12-120

OAAI

PrP is cleaved from the surface of mast cells by ADAM10 and proteases released during degranulation

PrP通过ADAM10和脱粒过程中释放的蛋白酶从肥大细胞表面裂解

JOURNAL OF LEUKOCYTE BIOLOGY

IF3.1

2024-05-100

German cockroach extract prevents IL-13-induced CCL26 expression in airway epithelial cells through IL-13 degradation

FASEB JOURNAL

IF4.2

2024-03-111

Road trip from mild to severe asthmatic inflammation: the traffic lights of biomarkers in asthma management

FRONTIERS IN MEDICINE

IF3

2023-11-300

OAAI

Searching for an Animal Model with Clinical Features of Scleroderma

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

IF5.3

2023-10-010

OAAI

Protease allergens as initiators-regulators of allergic inflammation

ALLERGY

IF12

2023-02-2636

Dual activation of estrogen receptor alpha and glucocorticoid receptor upregulate CRTh2-mediated type 2 inflammation; mechanism driving asthma severity in women?

ALLERGY

IF12

2022-10-195

The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females

FRONTIERS IN MEDICINE

IF3

2022-10-133

OAAI

Challenges in severe asthma: Do we need new drugs or new biomarkers?

FRONTIERS IN MEDICINE

IF3

2022-09-278

OAAI

Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity

FRONTIERS IN MEDICINE

IF3

2022-07-298

OAAI

Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice

嗜酸性粒细胞性哮喘，表型-内型和当前选择的生物标志物

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-06-3021

OAAI

Multidisciplinary Inflammatory Airway Team Experience

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2022-04-010

PRE

Th2 cell markers in peripheral blood increase during an acute asthma exacerbation

ALLERGY

IF12

2020-08-2016

PREAI

Elevated Circulating Th2 Cells in Women With Asthma and Psychological Morbidity: A New Asthma Endotype?

CLINICAL THERAPEUTICS

IF3.6

2020-06-012

OAAI

AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management

AAAAI肥大细胞疾病委员会工作组报告: 肥大细胞活化综合征 (MCAS) 的诊断和管理

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2019-10-0168

OAAI

Protease-Activated Receptor 2 Agonist as Adjuvant: Augmenting Development of Protective Memory CD8 T Cell Responses Induced by Influenza Virosomes

JOURNAL OF IMMUNOLOGY

IF3.4

2019-07-159

OAAI

IL-2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?

IL-2调节Th2细胞对糖皮质激素的反应: 持续性2型炎症的原因？

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2019-04-1720

OAAI

Harissios Vliagoftis

个人简介

教育背景

工作经历

荣誉奖项

研究方向